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Background: 
Necrotizing pancreatitis (NP) is a complex and heterogeneous disease with a protracted disease 
course. Hospital readmission is extremely common; however, few data exist regarding cause of 
readmission in NP.  
 
Methods: 
A retrospective review of NP patients treated between 2005-2017 identified patients readmitted 
both locally and to our hospital. All patients with unplanned hospital readmissions were 
evaluated to determine cause for readmission. Clinical and demographic factors of all patients 
were recorded. As appropriate, two independent groups t-tests and Pearson’s correlation or 
Fisher’s exact tests were performed to analyze the relationship between index admission clinical 
factors and readmission. P-values of <0.05 were accepted as statistically significant. 
 
Results: 
601 NP patients were reviewed. Median age was 52 years (13-96). Median index admission 
length of stay was 19 days (2-176). The most common etiology was biliary (49.9%) followed by 
alcohol (20.0%). Unplanned readmission occurred in 432 patients (72%) accounting for a total of 
971 unique readmissions (mean readmissions/patient - 2.3). The most common readmission 
indications were symptomatic necrosis requiring supportive care and/or intervention (31.2%), 
infected necrosis requiring antibiotics and/or intervention (26.6%), failure to thrive (9.7%), and 
non-necrosis infection (6.6%). Patients rering readmission had increased incidence of index 
admission renal failure (21.3% vs. 14.2%, p=0.05) and cardiovascular failure (12.5% vs. 4.7%, 
p=0.01). 
 
Discussion: 
Readmission in NP is extremely common. Significant portions of readmissions are a result of the 
disease natural history; however, a percentage of readmissions appear to be preventable. Patients 
with organ failure are at increased risk for unplanned readmission and will benefit from close 
follow-up.  
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Introduction 
Acute pancreatitis (AP) is an increasingly common indication for hospital admission and 
is associated with a significant financial burden to the health care system; this cost is estimated at 
over $2.2 billion annually(1). Most patients experience mild AP and recover uneventfully 
following a short hospital stay with little to no long-term sequelae. Patients with mild AP do not 
typically require readmission to the hospital following index admission. In contrast, severe acute 
pancreatitis (SAP) with pancreatic necrosis develops in 10-20% of all AP(1, 2) and is 
characterized by a prolonged hospital stay. These patients frequently require hospital 
readmission. Additionally, long-term sequelae in this population is much more common and 
often requires intervention. 
Necrotizing pancreatitis (NP) is a complex disease and carries significant morbidity with 
mortality ranging from 15-30%(3, 4). Morbidity includes organ failure, infectious complications, 
need for procedural intervention, malnutrition, and physical deconditioning. The result of this 
devastating disease process is an extremely high rate of hospital readmission and a prolonged 
recuperation. 
Readmission rate is an increasingly utilized metric of patient care quality(5). Given the 
cost burden readmission represents to the health care system, there is an ever-increasing interest 
in predicting and preventing hospital readmission to improve patient care efficiency and quality. 
In all patients with AP, readmission is seen in about 1 of every 5 patients. The more severe the 
sentinel episode, the more likely the risk of readmission (6-8). However, little is known about the 
incidence and etiology of readmission specifically in NP patients, the most vulnerable group.  
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We hypothesized that specific causes for readmission are identifiable and may allow the 
opportunity to treat patients preemptively, avoiding the need for unplanned hospital readmission. 
Therefore, the aim of this study is to evaluate the incidence and etiology of readmission 
following index admission with necrotizing pancreatitis and identify risk factors for readmission. 
Materials and Methods  
The institutional necrotizing pancreatitis database was reviewed to identify NP patients 
treated at Indiana University Health University Hospital (IU-UH) between 2005 and 2017. This 
database contains demographic and clinic information of 647 NP patients treated at IU-UH 
during that time. All patients were included regardless of etiology, age, or treatment strategy. 
Patients were excluded from review if they did not survive index admission or were lost to 
follow-up.  
Acute pancreatitis and severe acute pancreatitis were defined according to the revised 
Atlanta classification(9). Necrosis was identified as a lack of pancreatic parenchymal 
enhancement and/or findings of peripancreatic necrosis such as acute necrotic collection (ANC) 
or walled off necrosis (WON) on contrast enhanced cross sectional imaging(9). Dedicated 
faculty pancreatic radiologists confirmed necrosis in all cases. Index admission data include: age, 
sex, etiology, comorbidities, presence of organ failure (as defined according to the Modified 
Marshall scoring system for organ dysfunction(9, 10)), presence of infected necrosis, and need 
for intervention. 
Treatment during the patient’s index admission is largely supportive care and avoids 
intervention of pancreatic necrosis, if possible. Treatment strategy follows the consensus 
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guidelines as published by the International Association of Pancreatology and the American 
Pancreatic Association(11). 
Electronic medical records were queried for readmissions to IU-UH and to all hospitals in 
which electronic medical records are shared. All readmissions were captured in those patients 
included in the final analysis. This was accomplished via electronic medical records or through 
patient records at follow-up visits, as all patients are followed until disease resolution. 
Readmission dates, indication for readmission, and interventions were recorded. The time period 
for readmission was individualized to each patient - readmissions were included if they occurred 
prior to the individual patient’s disease resolution. Unplanned readmissions during the active 
disease were of interest. Planned readmissions were not included in the study and were defined 
as any readmission scheduled for planned intervention (percutaneous, endoscopic, or surgical). 
Additionally, readmissions resulting from long-term sequelae were not included in the analysis. 
Therefore, disease duration was recorded and all readmissions following resolution of NP were 
excluded from analysis.  
Two-tailed Student’s t-tests and Pearson’s correlations or Fisher’s exact tests were 
performed, as appropriate, to analyze the relationships between readmission and suspected risk 
factors identified during the index admission. P-values of <0.05 were accepted as statistically 
significant. Those factors with p-value >0.10 in univariate analysis were included in a 
multivariate analysis. All data were compiled and recorded in strict compliance with the 
protocols and guidelines set forth by the Institutional Review Board (IRB), which approved the 
conduct of this study. 
Results 
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Patient characteristics 
A total of 647 NP patients were treated between 2005 and 2017; 77% (501/647) of 
patients were transferred to our facility and the remaining 23% (146/647) were admitted 
primarily. Regional distribution of the NP patient population treated at IU-UH is show in Figure 
1. Median age at onset was 52 years (13-96) and 65.5% of patients were male. The most 
common etiology was biliary (49.6%), followed by alcohol (20.2%), hypertriglyceridemia 
(6.0%), post-ERCP (5.7%), and drug-induced (2.0%). Index admission mortality was 5.0% (32 
patients) and a total of 14 patients (2.2%) were lost to follow-up; 601 NP patients were therefore 
included in the analysis. The median time to disease resolution was 5 months (1-73) and median 
follow-up was 27 months (1-160). Overall mortality from necrotizing pancreatitis was 8.8%. 
Readmission 
At least one disease related unplanned readmission was seen in 432 patients (72%). The 
total number of unique unplanned readmissions was 971; each patient was readmitted an average 
of 2.3 times (+/-0.1, standard error). The most common indications for readmission were: 
infected necrosis requiring either antibiotic therapy or intervention (17.8%), symptomatic 
necrosis requiring supportive care (13.0%), symptomatic necrosis requiring intervention 
(11.0%), and failure to thrive (6.0%) (Figure 2). Etiologies of all unplanned readmissions are 
detailed in Table 1. 
Prediction of Readmission 
No pre-existing comorbidity was found to increase a patient’s risk for readmission 
(COPD, asthma, coronary artery disease, congestive heart failure, hypertension, diabetes, 
tobacco use, or obesity). The presence of clinical factors of interest during index admission in 
7 
 
each group is shown in Table 2. There was no significant difference in mean age, etiology, 
median index admission length of stay (LOS), infected necrosis, or respiratory failure in patients 
requiring readmission when compared to patients without readmission. Patients requiring 
necrosis intervention during the index hospital admission (n=169, 28.1%) had no difference in 
readmission rate when compared to those without intervention (69.8% vs. 75.0%, p=0.92). 
Patients requiring readmission were more likely to have developed renal or cardiovascular failure 
during the index hospital admission. The likelihood of readmission increased significantly with 
progressive organ failure (Figure 3).  
Discussion 
This retrospective analysis defines incidence, etiology, and risk factors for readmission 
following index admission in a large group of necrotizing pancreatitis patients treated at a high-
volume pancreatic quaternary referral center. Readmission following an episode of NP is 
extremely common (72%); much higher than that seen in other hepatopancreatobiliary 
pathology(12). Importantly, this study lends insight into reasons underlying readmission, which 
offers opportunity to improve clinical practice. 
Previous studies report rates of readmission in acute pancreatitis ranging from 19-34% (8, 
13). Moreover, these studies identified risk factors associated with readmission: male sex, 
alcohol etiology, admission to an intensive care unit, inpatient length of stay greater than 7 days, 
gastrointestinal symptoms at discharge, discharge on less than a solid diet, and discharge with 
drains in place(8, 13). Additionally, Whitlock et al developed a scoring system at discharge to 
predict 30-day readmission in all patients with acute pancreatitis - less than solid diet (3 points), 
GI symptoms (3 points), pancreatic necrosis (2 points), antibiotics (2 points), pain (1 point). 
Patients with a score of four or greater had between a 68-87% chance of 30-day hospital 
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readmission(14). Multiple risk factors and a high readmission risk score are present in nearly 
every NP patient, and therefore do not necessarily provide the additional clinical information 
required to identify those patients at highest risk for readmission among the NP population.  
Our findings are in accordance with previous studies that have shown increased severity 
of disease to correlate with increased readmission risk(6-8). However, etiology of readmission in 
NP has not been described by previous studies. A major finding of our current analysis is that 
one-third of readmissions are due to symptomatic necrosis and an additional one-quarter are due 
to infected necrosis. Thus, a large proportion of readmissions in NP are related to the natural 
history of the disease and as such, may not be preventable. In contrast, we identified several 
etiologies for readmission that may offer the ability to decrease readmission. These etiologies 
include: failure to thrive, non-necrosis infection, and tube dysfunction. Collectively, this group 
accounts for 21% of readmissions; initiatives to decrease readmission rates in NP should 
therefore target these problems. 
Necrotizing pancreatitis is a complex and heterogeneous problem best treated with a 
multidisciplinary approach and advanced techniques most often found at a specialty center. 
While treatment at regional referral centers provides full access to advanced treatment strategies, 
regionalization adds complexity to the follow-up care of each patient. The geographic 
distribution of our NP patient population is shown in Figure 1. The vast majority of our NP 
patients live more than 50 miles away; this distance adds challenge to continuing NP patient care 
through the several months long disease process.  
This study highlights an opportunity to coordinate the management of some NP-
associated problems to patient’s local services such as primary care physicians and community 
emergency rooms and hospitals. These problems include: symptomatic necrosis requiring 
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supportive care, failure to thrive, non-necrosis infection, and tube dysfunction – in total 
accounting for 48% of readmissions identified in the current analysis. Obviously, coordinated 
communication between dedicated caregivers at the local and regional treatment centers is 
critical to this shared care model. More complex problems will continue to require management 
at specialty centers, particularly symptomatic necrosis requiring intervention, infected necrosis, 
disconnected pancreatic duct syndrome, gastrointestinal fistula, pancreaticobiliary stricture, and 
hemorrhage. This paradigm of shared regional and specialty center care mandates excellent 
communication between physicians. 
The results of this study have sparked several important changes in our necrotizing 
pancreatitis practice. Patients at high-risk for readmission, particularly those who developed 
organ failure during their index admission, are targeted for close follow-up (ideally, one to two 
weeks following discharge). Additionally, a dedicated pancreatitis nurse coordinator has been 
tasked with frequent communication with high-risk patients (one to two times per week) to 
identify developing deviations from expected recovery. Patients with more straightforward 
problems, as able, are managed at local facilities with frequent communication between the local 
physician and responsible hepatopancreatobiliary surgeon or medical pancreatologists. The 
combination of early follow-up and frequent communication with patients will ideally improve 
the ability to plan admissions when intervention is required. 
Strategies aimed to decrease hospital readmission are often focused on post-discharge 
care. It may be possible to improve treatment strategies in these patients during the initial 
hospital admission which can decrease unplanned readmission. However, it appears that no 
particular treatment or necrosis intervention during the index admission effects readmission rate. 
This highlights the fact that currently no treatment exists to modulate the disease course in NP; 
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treatment is strictly supportive and reactive. Additionally, no consensus discharge criteria exist in 
NP patients. The development of standardized discharge criteria in this population is the scope of 
future projects. Unplanned readmission rates may improve with discharge criteria individualized 
to the necrotizing pancreatitis patient population. 
This study is limited by is retrospective nature – chart review may not completely capture 
the patient’s clinical picture at the time of readmission. Due to the complexity of necrotizing 
pancreatitis, many patients are likely readmitted with a combination of pathology, and not one 
specific problem resulting in readmission. Nevertheless, thorough analysis of these data has 
identified several clearly consistent categories of readmission etiology. An important strength of 
this study is its high-volume nature and thorough long-term statewide follow up, both of which 
are difficult to obtain in this extremely complicated patient population. 
Conclusion 
The complex disease process of necrotizing pancreatitis results in an extremely high rate 
of hospital readmission – 72%. A portion of hospital readmissions are unavoidable as they are 
inherent to this long-term disease. All necrotizing pancreatitis patients should be considered 
high-risk for readmission; however, this analysis has identified patients with increasing numbers 
of organ failure to be the highest-risk population for readmission. Close follow-up and frequent 
communication with local primary care providers are strategies to decrease readmission in this 
vulnerable population.  
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Figure 1: Distribution of necrotizing pancreatitis patients treated at Indiana University Health 
University Hospital between 2005 and 2017. The Indiana University (IU) logo represents the 
location of our University Hospital. 
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Figure 2:Readmission in necrotizing pancreatitis and the most common etiologies 
 
14 
 
Table 1: Indication for unplanned readmission by diagnosis (total number of unplanned 
readmissions = 971). Abbreviations: CLABSI – central-line associated blood stream infection.  
Admission indication n (%) 
Symptomatic necrosis 
Supportive care 
Percutaneous drain 
Endoscopic therapy 
Operative therapy 
303 (31.2%) 
167 (17.2%) 
10 (1.0%) 
24 (2.5%) 
102 (10.5%) 
Infected necrosis 
Antibiotics 
Percutaneous drain 
Endoscopic therapy 
Operative therapy 
258 (26.6%) 
30 (3.1%) 
109 (11.2%) 
6 (0.6%) 
113 (11.6%) 
Failure to thrive 94 (9.7%) 
Infection, non-necrosis 
CLABSI 
Pneumonia 
Urinary tract infection 
C. difficile 
Cholangitis 
64 (6.6%) 
22 (2.3%) 
17 (1.8%) 
10 (1.0%) 
9 (0.9%) 
6 (0.6%) 
Gastrointestinal fistula 46 (4.7%) 
Tube dysfunction 
Percutaneous drain 
Feeding tube 
46 (4.7%) 
33 (3.4%) 
13 (1.3%) 
Disconnected pancreatic duct syndrome 38 (3.9%) 
Pancreatico-biliary stricture 
Biliary 
Duodenal 
Pancreatic duct 
30 (3.1%) 
20 (2.1%) 
7 (0.7%) 
3 (0.3%) 
Hemorrhage 
Pseudoaneurysm 
Percutaneous drain  
Gastrointestinal 
35 (3.6%) 
17 (1.8%) 
11 (1.1%) 
7 (0.7%) 
Venous thromboembolism 12 (1.2%) 
Bowel obstruction/perforation/ischemia 9 (0.9%) 
Wound complication 7 (0.7%) 
Recurrent acute pancreatitis 4 (0.4%) 
Cardiac events 4 (0.4%) 
Other/unknown 28 (2.9%) 
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Table 2: Clinical factors of interest and comparison between groups (readmission vs. no 
readmission). Bolded values represent statistical significance with p-value <0.05. Abbreviations: 
LOS - index admission length of stay 
Variable Readmission No readmission p-value 
Age, years (mean +/- SD) 52.5 +/- 15.3 49.9 +/- 15.5 0.06 
Median LOS, days 19 20 0.17 
Infected necrosis (%) 19.9% 19.5% 0.92 
Intervention - index admission (%) 25.0% 30.2% 0.92 
Respiratory failure (%) 30.6% 25.4% 0.22 
Renal failure (%) 21.3% 14.2% 0.05 
Cardiovascular failure (%) 12.5% 4.7% 0.01 
Number of organ failure 
0 
1 
2 
3 
 
61.6% 
17.4% 
12.3% 
8.8% 
 
69.2% 
17.2% 
9.5% 
4.1% 
0.02 
 
  
16 
 
Figure 3: Readmission risk increases with progressive organ failure. This trend of increasing 
readmission risk is statistically significant, p=0.02. 
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